Product Code: ETC6190733 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
This healthcare market segment includes devices that enable diabetic patients to monitor their blood glucose levels independently. The Australia market growth is supported by rising diabetes prevalence, increasing awareness, and advancements in portable, user-friendly, and accurate monitoring technologies. Integration with digital health platforms is an emerging trend.
This market is expanding rapidly driven by the increasing prevalence of diabetes and growing awareness of self-care. Innovations include continuous glucose monitoring systems, non-invasive devices, and integration with mobile health apps for better management. The trend toward personalized healthcare and remote monitoring is shaping product development and adoption in Australia.
This healthcare market faces regulatory challenges regarding device approvals, accuracy standards, and data privacy concerns linked to connected health devices. High costs of advanced glucose monitoring technologies can limit accessibility. Patient compliance and education remain critical issues for effective self-monitoring. Additionally, competition from continuous glucose monitoring (CGM) systems and smartphone app integration pressures traditional device manufacturers. Supply chain disruptions can affect availability of components.
With the growing prevalence of diabetes in Australia, the market for self-monitoring blood glucose (SMBG) devices is expanding rapidly. Investors can explore opportunities in next-generation SMBG technologies including Bluetooth-enabled, smartphone-compatible, and minimally invasive devices. Partnerships with healthcare providers and retail pharmacies can aid in the widespread adoption of these devices, especially in rural and underserved regions.
This market is guided by policies from the Therapeutic Goods Administration (TGA), which regulates the approval, quality, and safety of medical devices. The National Diabetes Services Scheme (NDSS) subsidizes blood glucose monitoring devices for patients, encouraging wider access. Government procurement standards and Medicare reimbursements also significantly impact market dynamics and pricing strategies for manufacturers.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Self-Monitoring Blood Glucose Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Self-Monitoring Blood Glucose Devices Market - Industry Life Cycle |
3.4 Australia Self-Monitoring Blood Glucose Devices Market - Porter's Five Forces |
3.5 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume Share, By Components, 2021 & 2031F |
3.6 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Australia Self-Monitoring Blood Glucose Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Australia |
4.2.2 Growing awareness about the importance of self-monitoring blood glucose levels |
4.2.3 Technological advancements in blood glucose monitoring devices |
4.3 Market Restraints |
4.3.1 High cost associated with self-monitoring blood glucose devices |
4.3.2 Limited reimbursement policies for self-monitoring blood glucose devices |
5 Australia Self-Monitoring Blood Glucose Devices Market Trends |
6 Australia Self-Monitoring Blood Glucose Devices Market, By Types |
6.1 Australia Self-Monitoring Blood Glucose Devices Market, By Components |
6.1.1 Overview and Analysis |
6.1.2 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume, By Components, 2021- 2031F |
6.1.3 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume, By Glucometer Devices, 2021- 2031F |
6.1.4 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume, By Test Strips, 2021- 2031F |
6.1.5 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume, By Lancets, 2021- 2031F |
6.2 Australia Self-Monitoring Blood Glucose Devices Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume, By Hospitals/Clinics, 2021- 2031F |
6.2.3 Australia Self-Monitoring Blood Glucose Devices Market Revenues & Volume, By Home/Personal, 2021- 2031F |
7 Australia Self-Monitoring Blood Glucose Devices Market Import-Export Trade Statistics |
7.1 Australia Self-Monitoring Blood Glucose Devices Market Export to Major Countries |
7.2 Australia Self-Monitoring Blood Glucose Devices Market Imports from Major Countries |
8 Australia Self-Monitoring Blood Glucose Devices Market Key Performance Indicators |
8.1 Adoption rate of self-monitoring blood glucose devices among diabetes patients |
8.2 Average frequency of blood glucose testing using self-monitoring devices |
8.3 Number of new entrants or innovations in the self-monitoring blood glucose devices market |
9 Australia Self-Monitoring Blood Glucose Devices Market - Opportunity Assessment |
9.1 Australia Self-Monitoring Blood Glucose Devices Market Opportunity Assessment, By Components, 2021 & 2031F |
9.2 Australia Self-Monitoring Blood Glucose Devices Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Australia Self-Monitoring Blood Glucose Devices Market - Competitive Landscape |
10.1 Australia Self-Monitoring Blood Glucose Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Self-Monitoring Blood Glucose Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |